Navigation Links
FDA Panel Considers Toll-Free Number for TV Drug Ads
Date:5/16/2008

Consumers could report side effects, but critics want agency to act, not wait years

FRIDAY, May 16 (HealthDay News) -- Direct-to-consumer drug ads on television should include a toll-free phone number that would allow consumers to report adverse side effects, U.S. health experts suggested Friday.

The experts serve on a panel that advises the U.S. Food and Drug Administration. Such phone numbers are already mandated by the FDA for print ads. At Friday's meeting, the panel discussed designing a study to determine the most effective way of adding the phone number to TV ads.

FDA spokeswoman Rita Chappelle said the agency would look at the panel's recommendations and incorporate them into the design of a study to determine the best way to include a toll-free number in TV ads. After the study is done, the next step would be to issue regulations and get Congressional approval before they could take effect, she said.

"It could take some time," Chappelle said. "It could take a couple of years."

Chappelle noted that because television is a different medium from print, the best way to put a toll-free number on television ads needs to be studied. Among the factors that require consideration are the best place to put the number and how long it should stay on the screen, she said.

Congress asked the FDA to evaluate adding toll-free numbers to TV ads to get a better understanding of drugs' adverse effects after being approved.

Friday's actions proved disappointing to some consumer advocates, who would like to see faster action on a toll-free number for TV ads.

"We want to make sure that this information gets into TV ads sooner, not later," said Elizabeth Foley, a policy advocate for Consumers Union, who testified before the panel. "We want to figure out if there is a way for the FDA to shorten the time it takes to do a study on this proposal."

Consumers Union wants the FDA to require a toll-free number and a Web site address on all TV drug ads, Foley said. "It's already required for print ads, let's just expanded it to TV ads," she said.

Foley said it's important that consumers have a way to report adverse side effects. "Most of the time, drugs are only tested on a very small number of people, and it's not until the drug is on the market that we start to see serious side effects," she said. "That's when the real test happens."

For example, the potentially deadly cardiovascular side effects of the arthritis drug Vioxx weren't discovered until the drug had been on the market for several years.

The FDA does have a method for consumers to report adverse side effects from drugs. However, according to a Consumer Reports survey, most people who report serious side effects report them to their doctor; only 7 percent report them to the FDA, Foley said.

Direct-to-consumer advertising generates billions of dollars in sales for both drug companies and the television industry. In 1997, the federal government eased the rules on advertising on TV and radio, allowing drug companies to shorten the warnings on side effects in commercials. Since that time, drug companies have spent an estimated $14 billion advertising prescription medications on broadcast and cable TV, according to the Dow Jones Newswires.

Some recent direct-to-consumer drug ads have come under fire from consumer advocates. The drug makers Merck and Schering-Plough were criticized for promoting the cholesterol drug Vytorin, while not disclosing studies that questioned the drug's effectiveness. And Pfizer was criticized for ads promoting its cholesterol-lowering drug Lipitor that featured Dr. Robert Jarvik, who is not a practicing medical doctor, Dow Jones reported.

More information

For more on direct-to-consumer drug ads, visit the FDA.



SOURCES: Rita Chappelle, spokeswoman, U.S. Food and Drug Administration; Elizabeth Foley, policy advocate, Consumers Union; May 16, 2008, Dow Jones


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. National Coalition for Quality Colorectal Cancer Screening and Care Testifies Before FDA Advisory Panel on Fospropofol Labeling:
2. FDA Panel Urges Stronger Warnings for LASIK Surgery
3. Inforum Presents Panel Discussion on The Future of the U.S. Health Care System: What It Will Cost in Dollars and Quality of Care
4. UHW Joins Blue Ribbon Panel on the Future of St. Lukes Hospital
5. FDA Panel Supports Anemia Drugs for Cancer Patients
6. FDA Panel Weighs Safety of Anemia Drugs for Cancer Patients
7. Nasdaq Hearings Panel Grants TeamStaffs Request for Continued Listing Subject to a Reverse Stock Split
8. Is Cancer Community in Alignment About Cure and Costs? NCCN Conference Panel Asks
9. CDC Panel Urges Extending Flu Vaccine Coverage for Kids
10. Key Business, Labor and Academic Experts Join Stop Obesity Alliance Panel to Present Policy Perspectives and Recommendations to Reshape The Union
11. FDA Panel OKs 3 New Flu Strains for Next Years Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
(Date:6/24/2016)... Georgia (PRWEB) , ... June 24, 2016 , ... ... awards today at the Clinical Decision Making in Emergency Medicine conference in Ponte ... have authored journal articles published in Emergency Medicine Practice and Pediatric ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016  In a startling report released today, National Safety ... lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... how states are tackling the worst drug crisis in recorded U.S. ... Kentucky , New Mexico , ... Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
Breaking Medicine Technology: